US Stock MarketDetailed Quotes
AGEN Agenus
- 3.550
- +0.210+6.29%
Close Nov 25 16:00 ET
- 3.650
- +0.100+2.82%
Post 17:40 ET
83.28MMarket Cap-322P/E (TTM)
3.890High3.420Low931.02KVolume3.440Open3.340Pre Close3.39MTurnover4.02%Turnover RatioLossP/E (Static)23.46MShares19.68852wk High-0.28P/B82.17MFloat Cap2.50052wk Low--Dividend TTM23.15MShs Float8419.554Historical High--Div YieldTTM14.07%Amplitude2.500Historical Low3.641Avg Price1Lot Size
About Agenus Company
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Company Profile
SymbolAGEN
Company NameAgenus
Listing DateFeb 4, 2000
Issue Price18.00
Founded1994
CEODr. Garo H. Armen, PhD
MarketNASDAQ
Employees389
Fiscal Year Ends12-31
Address3 Forbes Road
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421-7305
Phone1-781-674-4400
Websitehttp://www.agenusbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Garo H. Armen, PhD
- Chairman of the Board and Chief Executive Officer
- 5.86M
- Steven J. O'Day
- Chief Medical Officer
- 1.44M
- Christine M. Klaskin
- Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
- 712.75K
- Thomas L. Harrison
- Director
- --
- Dr. Jennifer S. Buell, PhD
- Director
- --
- Timothy R. Wright
- Lead Independent Director
- 385.50K
- Susan B. Hirsch
- Independent Director
- 242.00K
- Brian J. Corvese
- Independent Director
- 888.14K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
